Genetic landscape of gallbladder cancer: Global overview
Autor: | Sandeep Singh, Sundeep Singh Saluja, Ravi Mehrotra, Pranay Tanwar, Milind Javle, Bhawna Sirohi, Balraj Mittal, Asiya Khan, Tanvir Kaur, Manal M. Hassan, Shubham Pant, Showket Hussain, Xabier de Aretxabala, Preetha Rajaraman, Sonam Tulsyan, Goura Kisor Rath |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Candidate gene Health Toxicology and Mutagenesis Genome-wide association study Disease Computational biology Biology Malignancy 03 medical and health sciences 0302 clinical medicine Genetics medicine Humans Genetic Predisposition to Disease Liquid biopsy Gallbladder cancer Germ-Line Mutation COSMIC cancer database Genetic heterogeneity High-Throughput Nucleotide Sequencing medicine.disease Biliary Tract Neoplasms 030104 developmental biology 030220 oncology & carcinogenesis Gallbladder Neoplasms Genome-Wide Association Study |
Zdroj: | Mutation Research/Reviews in Mutation Research. 778:61-71 |
ISSN: | 1383-5742 |
DOI: | 10.1016/j.mrrev.2018.08.003 |
Popis: | Gallbladder cancer (GBC) is a rare malignancy of biliary tract cancer (BTC), characterized by late presentation and poor prognosis. It exhibits wide geographical as well as ethnical variations. So, diverse epidemiology along with etiological factors have been discussed in the current article. Present review unravels the germ line polymorphisms contributing to GBC susceptibility through candidate gene approach and GWAS. GBC is enriched with multiple mutations consisting of both passenger and driver mutations. The identification of the hotspot driver mutations which are involved in the etiopathogenesis of this cancer is necessary, before targeted therapies could be implemented clinically. Thus, this review sheds lights on both traditional low throughput methods along with high throughput NGS used to determine somatic mutations in cancer. With the advent of GWAS and high throughput sequencing methods, it is possible to comprehend the mutational landscape of this enigmatic disease. This article is the first one to provide insights into the genetic heterogeneity of GBC along with somatic mutational data from Catalogue of Somatic Mutations in Cancer (COSMIC) database. In addition, management of tumor heterogeneity as a therapeutic challenge has been discussed. Future goals involve liquid biopsy based research for better clinical management of the disease. Therefore, research efforts involving discovery of non- invasive markers for early stage cancer detection along with novel therapies should be directed. |
Databáze: | OpenAIRE |
Externí odkaz: |